Asthma Control Through Telemedicine (PLET-I)

Hamdard University

Status: Not yet enrolling

Conditions: Asthmatic Patients

Treatments: Other: Educational

Study type: Interventional

Funder types: Other

Identifiers

NCT06863285

ABJan012025

Details and patient eligibility

About

The purpose of this research study is to evaluate the impact of pharmacist led educational interventions on Asthmatic patients, and also determine their medication adherence.

Pharmacist's intervention aims to answer:

1. How a pharmacist intervention program impact medication adherence in persistent asthma?
2. To assess how pharmacist led educational intervention like patients' counseling and medication reminders through Telemedicine have an impact on patient's asthma control?
3. Which mode of communication (Verbal instructions, videos and pamphlets) for the patient counselling is most beneficial for the patients in asthma control.

Full description

This is a randomized, pharmacist-led, two-group, longitudinal descriptive interventional study performed through in person (Public and private hospitals) and telecommunication (WhatsApp, network calls and messaging). The investigator will use snowball method to approach patients through telecommunication. Recruited patients will be randomly divided into two groups: the Control and the experimental group. The Control Group will not receive any intervention, and experimental group will receive special counseling about persistent asthma, it's medications and medical devices, their appropriate use, and side effects. Using Telemedicine as message and call reminders to increase medication adherence and improve their asthmatic condition. The intervention will be conducted for one month on the experimental group according to the recruitment date and time of the patients.

Pre-validated questionnaires will be used for the assessment

1. The adherence to asthma medication questionnaire (AAMQ-13).
2. Asthma Control test TM (ACT).

Enrollment: 140 estimated patients

Sex: All

Ages: 11+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age above 11 years.
• Persistent Asthma Patient.
• Patients taking medications and inhaler.
• Patient who will consent for the study.
• Patient with basic telecommunication facility.
• Patient who responded to messages and calls.

Exclusion criteria

• Patients who will refuse to participate in study will not be included.
• Irresponsive patients to messages and calls

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

140 participants in 2 patient groups

Study group

Experimental group

Description:

intervention included the usual counselling by pharmacist e.g. Patients Education regarding Medications * Pharmacist counseling patients regarding their disease and severity * Pharmacist counseling (5- to 10-minute sessions) on the proper and safe use of medication. * Pharmacist counseling patients regarding the importance of their therapy (treatment), non-pharmacological treatment like diet and exercises. pharmacist counselling regarding the preventive measures that prevent patient from triggers that can initiate asthmatic attacks.

Treatment:

Other: Educational

Control group

No Intervention group

Description:

No intervention